NEW YORK (GenomeWeb) – GenomeDx and pathology firm Pathnostics said today that they have entered a strategic agreement under which GenomeDx will market and distribute Pathnostics' Guidance UGx and Guidance PRx tests.

The two tests diagnose urinary tract infections (UTIs) and prostatitis, respectively. Both use quantitative PCR to detect the presence of pathogens and to measure molecular signs of antibiotic resistance. According to Pathnostics, this provides a faster and more comprehensive solution than traditional culture methods.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.